Status:
WITHDRAWN
Collection of Retrospective (Archival) Samples and Prospective Collection of Surplus Tissue and Blood Samples
Lead Sponsor:
Global BioClinical
Conditions:
Cancer
Eligibility:
All Genders
18+ years
Brief Summary
This study will enroll specimens from subjects diagnosed with various cancers and who have either: 1. RETROSPEFCTIVE / ARCHIVAL SAMPLES already undergone surgical resection of their tumor and have on...
Detailed Description
CANCER INDICATIONS: Bladder Cancer - Urothelial carcinoma - nonpapillary Bladder Cancer - Urothelial carcinoma - papillary Brain Cancer - Astrocytoma Brain Cancer - Glioblastoma Brain Cancer - Medull...
Eligibility Criteria
Inclusion
- Any adult age
- Any sex
- Able to provide consent for surplus tissue and/or blood donation
- Diagnosed with one of the cancer indications listed below:
- Scheduled to undergo surgical resection of tumor (exception for hematological cancers)
- Have not yet received treatment for cancer
Exclusion
- Not diagnosed with required cancer indication
- Not scheduled to undergo surgical resection of the tumor
- Have already received cancer treatment (such as chemotherapy, radiation, surgery) for the current cancer or a previously diagnosed cancer
- Not able to donate an adequate volume of blood to meet minimum requirements
Key Trial Info
Start Date :
March 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 27 2023
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT02239575
Start Date
March 1 2014
End Date
February 27 2023
Last Update
February 28 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Global BioClinical
Seattle, Washington, United States, 98104